{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:59:44Z","timestamp":1783511984990,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.aprim.2022.102367","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T06:24:15Z","timestamp":1653891855000},"page":"102367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Deprescripci\u00f3n en personas mayores: es el momento de pasar a la acci\u00f3n"],"prefix":"10.1016","volume":"54","author":[{"given":"Rosa Ana","family":"Garc\u00eda Pliego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Baena D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Herreros Herreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Acosta Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102367_bib0155","unstructured":"Eurostat. Proportion of population aged 65 and over [consultado 18 Nov 2021]. Disponible en: https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/tps00028\/default\/table?lang=en"},{"key":"10.1016\/j.aprim.2022.102367_bib0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/pds.4956","article-title":"Evolution of polypharmacy in a Spanish population (2005-2015): A database study","volume":"29","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.aprim.2022.102367_bib0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aprim.2018.09.001","article-title":"Deprescribiendo para mejorar la salud de las personas o cuando deprescribir puede ser la mejor medicina","volume":"50","author":"Esteban Jim\u00e9nez","year":"2018","journal-title":"Aten Primaria."},{"issue":"Suppl 2","key":"10.1016\/j.aprim.2022.102367_bib0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.aprim.2020.09.005","article-title":"Actualizaci\u00f3n PAPPS GdT Mayor 2020","volume":"52","author":"Gorro\u00f1ogoitia Iturbe","year":"2020","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102367_bib0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18773\/austprescr.2020.033","article-title":"Deprescribing in older people","volume":"43","author":"Liacos","year":"2020","journal-title":"Aust Prescr."},{"key":"10.1016\/j.aprim.2022.102367_bib0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.18773\/austprescr.2011.095","article-title":"Deprescribing","volume":"34","author":"Le Coteur","year":"2011","journal-title":"Aust Prescr."},{"key":"10.1016\/j.aprim.2022.102367_bib0185","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101030","article-title":"Barriers and facilitators to primary health care for people with intellectual disabilities and\/or autism: An integrative review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open."},{"key":"10.1016\/j.aprim.2022.102367_bib0190","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/dom.13724","article-title":"Deintensification in older patients with type2 diabetes: A systematic review of approaches, rates and outcomes","volume":"21","author":"Seidu","year":"2019","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.aprim.2022.102367_bib0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12875-021-01557-y","article-title":"Anti-hypertensive drugs deprescribing: An updated systematic review of clinical trials","volume":"22","author":"Crisafulli","year":"2021","journal-title":"BMC Fam Pract."},{"key":"10.1016\/j.aprim.2022.102367_bib0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: asystematic review and meta-analysis","volume":"82","author":"Page","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.aprim.2022.102367_bib0205","article-title":"Polimedicaci\u00f3n y medicaci\u00f3n inapropiada","author":"Rodr\u00edguez L\u00f3pez","year":"2020","journal-title":"Fisterra."},{"key":"10.1016\/j.aprim.2022.102367_bib0210","first-page":"1","article-title":"Polimedicaci\u00f3n y deprescripci\u00f3n: recomendaciones pr\u00e1cticas","volume":"36","year":"2021","journal-title":"Bol Ter Andal."},{"key":"10.1016\/j.aprim.2022.102367_bib0215","unstructured":"Steinman M, Reeve E. Deprescribing. En: UpToDate, Schmader KE (Ed). Waltham, Mass: UpToDate. Actualizado en abril 2021 [consultado 13 Nov 2021]. Disponible en: https:\/\/www-uptodate-com.bvcscm.a17.csinet.es\/contents\/deprescribing?search=deprescribing&source=search_result&selectedTitle=1\u223c150&usage_type=default&display_rank=1"},{"key":"10.1016\/j.aprim.2022.102367_bib0220","first-page":"1","article-title":"Deprescribing techniques to minimize safety issues associated with inappropriate polypharmacy","volume":"11","author":"Molina","year":"2021","journal-title":"The Oregon State Drug Review."},{"key":"10.1016\/j.aprim.2022.102367_bib0225","unstructured":"Scottish Government Polypharmacy Model of Care Group. Polypharmacy Guidance, Realistic Prescribing. 3rd edition, 2018. Scottish Government [consultado 12 Feb 2022]. Disponible en. https:\/\/www.therapeutics.scot.nhs.uk\/wp-content\/uploads\/2018\/04\/Polypharmacy-Guidance-2018.pdf"},{"key":"10.1016\/j.aprim.2022.102367_bib0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.recesp.2010.11.005","article-title":"Factores de riesgo cardiovascular en Espa\u00f1a en la primera d\u00e9cada del sigloxxi: an\u00e1lisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS","volume":"64","author":"Grau","year":"2011","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.aprim.2022.102367_bib0235","first-page":"CD012572","article-title":"Withdrawal of antihypertensive drugs in older people","volume":"6","author":"Reeve","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102367_bib0240","doi-asserted-by":"crossref","first-page":"e14408","DOI":"10.1111\/dme.14408","article-title":"Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review","volume":"38","author":"Oktora","year":"2021","journal-title":"Diabet Med."},{"key":"10.1016\/j.aprim.2022.102367_bib0245","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can Fam Physician."},{"key":"10.1016\/j.aprim.2022.102367_bib0250","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.aprim.2022.102367_bib0255","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.aprim.2022.102367_bib0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.gaceta.2019.06.012","article-title":"Benzocarta: intervenci\u00f3n m\u00ednima para la desprescripci\u00f3n de benzodiacepinas en pacientes con insomnio","volume":"34","author":"Baza Bueno","year":"2020","journal-title":"Gac Sanit."},{"key":"10.1016\/j.aprim.2022.102367_bib0265","first-page":"CD011969","article-title":"Deprescribing versus continuation of chronic proton pump inhibitor use in adults","volume":"3","author":"Boghossian","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102367_bib0270","doi-asserted-by":"crossref","first-page":"102191","DOI":"10.1016\/j.aprim.2021.102191","article-title":"Intervenci\u00f3n para la deprescripci\u00f3n de inhibidores de la bomba de protones mediante env\u00edo de carta (IBP-carta)","volume":"54","author":"Ruiz de Velasco Artaza","year":"2021","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102367_bib0275","first-page":"15","article-title":"Carga anticolin\u00e9rgica: recomendaciones","volume":"36","year":"2021","journal-title":"Bol Ter Andal."},{"issue":"Suppl 2","key":"10.1016\/j.aprim.2022.102367_bib0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.aprim.2018.09.003","volume":"50","author":"Fern\u00e1ndez Dom\u00ednguez","year":"2018","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102367_bib0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jagp.2017.09.027","article-title":"A systematic review of practice guidelines and recommendations for discontinuation of cholinesterase inhibitors in dementia","volume":"26","author":"Renn","year":"2018","journal-title":"Am J Geriatr Psychiatry."},{"key":"10.1016\/j.aprim.2022.102367_bib0290","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: A systematic review and meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.aprim.2022.102367_bib0295","unstructured":"Polimedicaci\u00f3n y deprescripci\u00f3n: Herramientas. Destacado CADIME. 2019 [consultado 30 Oct 2021]. Disponible en: https:\/\/www.cadime.es\/noticias\/destacados\/305-polimedicaci%C3%B3n-y-deprescripci%C3%B3n-herramientas.html"},{"key":"10.1016\/j.aprim.2022.102367_bib0300","article-title":"Using tools to support medication review","author":"Barnett","year":"2021","journal-title":"NHS England."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:01:44Z","timestamp":1759323704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0212656722000877"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102367","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprescripci\u00f3n en personas mayores: es el momento de pasar a la acci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102367"}}